Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
Natl Toxicol Program Tech Rep Ser. 2016 Apr(585). doi: 10.22427/NTP-TR-585.
Dried concentrated extracts from Camellia sinensis contain high amounts of catechins and are a popular source for green tea extract nutraceutical supplements and medicinal uses. Supplements containing green tea extract are commonly consumed for weight loss and green tea extracts are popular ingredients in sunblocks, cream rinses, and other cosmetics. Numerous studies in both experimental animals and clinical settings have examined the possible anticancer, anti-inflammatory, antimicrobial, and cardio- and neuroprotective properties of green tea extract. The presumed active ingredient of green tea extract, epigallocatechin gallate (EGCG), was originally nominated by the National Cancer Institute for toxicity and carcinogenicity studies because it is the most abundant catechin in green tea extract, it was being investigated as a potential chemotherapeutic agent, and there was a lack of adequate information with regard to its toxicity. However, the NTP selected green tea extract [containing EGCG (48.4% by weight) and other green tea catechins] for study because human exposure is to green tea extract products that contain concentrated mixtures of various green tea catechins. The NTP analyzed four lots of green tea extract and selected a source based on quantities of EGCG, consistency with other products on the market, and availability in bulk quantity. Oral gavage was chosen as the route of administration because it was considered most relevant to human exposure. Male and female F344/NTac rats and B6C3F1/N mice were administered green tea extract in water by gavage for 3 months and male and female Wistar Han [Crl:WI(Han)] rats (referred to as Wistar Han rats) and B6C3F1/N mice were administered green tea extract in water by gavage for 2 years. Genetic toxicology studies were conducted in Salmonella typhimurium, Escherichia coli, and mouse peripheral blood erythrocytes. (Abstract Abridged).
茶树的干燥浓缩提取物含有大量儿茶素,是绿茶提取物营养补充剂和药用的常见来源。含绿茶提取物的补充剂常用于减肥,绿茶提取物也是防晒霜、润丝精和其他化妆品中的常见成分。在实验动物和临床环境中都进行了大量研究,以探究绿茶提取物可能具有的抗癌、抗炎、抗菌以及心脏和神经保护特性。绿茶提取物的假定活性成分表没食子儿茶素没食子酸酯(EGCG)最初被美国国家癌症研究所提名为毒性和致癌性研究对象,因为它是绿茶提取物中含量最丰富的儿茶素,当时正作为一种潜在的化疗药物进行研究,且关于其毒性的信息不足。然而,美国国家毒理学计划(NTP)选择了绿茶提取物[含有EGCG(重量占比48.4%)和其他绿茶儿茶素]进行研究,因为人类接触的是含有各种绿茶儿茶素浓缩混合物的绿茶提取物产品。NTP分析了四批绿茶提取物,并根据EGCG的含量、与市场上其他产品的一致性以及批量供应情况选择了一个来源。选择经口灌胃作为给药途径,因为它被认为与人类接触情况最为相关。通过经口灌胃的方式,给雄性和雌性F344/NTac大鼠以及B6C3F1/N小鼠喂食绿茶提取物水溶液,持续3个月;给雄性和雌性Wistar Han [Crl:WI(Han)]大鼠(简称Wistar Han大鼠)以及B6C3F1/N小鼠喂食绿茶提取物水溶液,持续2年。在鼠伤寒沙门氏菌、大肠杆菌和小鼠外周血红细胞中进行了遗传毒理学研究。(摘要节略)